Prestige Biopharma co-founder Lisa Park says that drug development has always been her "dream and goal". She reckons that the timing is now optimal to pursue an IPO as investor appetite for a biotech play on the Korea Exchange appears buoyant.
Caption: 
Prestige Biopharma co-founder Lisa Park says that drug development has always been her "dream and goal". She reckons that the timing is now optimal to pursue an IPO as investor appetite for a biotech play on the Korea Exchange appears buoyant.